169 related articles for article (PubMed ID: 28150570)
1. Identification, Characterization, and Quantification of Impurities of Safinamide Mesilate: Process-Related Impurities and Degradation Products.
Zou L; Sun L; Zhang H; Hui W; Zou Q; Zhu Z
J AOAC Int; 2017 Jul; 100(4):1029-1037. PubMed ID: 28150570
[TBL] [Abstract][Full Text] [Related]
2. Characterization of process-related impurities including forced degradation products of alogliptin benzoate and the development of the corresponding reversed-phase high-performance liquid chromatography method.
Zhou Y; Zhou W; Sun L; Zou Q; Wei P; OuYang P
J Sep Sci; 2014 Jun; 37(11):1248-55. PubMed ID: 24616424
[TBL] [Abstract][Full Text] [Related]
3. A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesilate, a new anti-Parkinson drug.
Zhang K; Xue N; Shi X; Liu W; Meng J; Du Y
J Pharm Biomed Anal; 2011 Apr; 55(1):220-4. PubMed ID: 21277726
[TBL] [Abstract][Full Text] [Related]
4. Identification, Characterization and HPLC Quantification of Process-Related Impurities in Bepotastine Besilate Bulk Drug.
Zhang C; Han C; Sun L; Yu J; Zou Q
Drug Res (Stuttg); 2020 Jan; 70(1):12-22. PubMed ID: 31539916
[TBL] [Abstract][Full Text] [Related]
5. Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.
Yan F; Liu J; Zeng X; Zhang Y; Hang T
Malar J; 2014 Oct; 13():401. PubMed ID: 25311421
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
[TBL] [Abstract][Full Text] [Related]
7. Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds.
Gao S; Meng L; Zhao C; Zhang T; Qiu P; Zhang F
Molecules; 2018 Nov; 23(12):. PubMed ID: 30501039
[TBL] [Abstract][Full Text] [Related]
8. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.
Zhang H; Sun L; Zou L; Hui W; Liu L; Zou Q; Ouyang P
J Pharm Biomed Anal; 2016 Sep; 128():18-27. PubMed ID: 27209451
[TBL] [Abstract][Full Text] [Related]
9. Identification, synthesis and structural characterization of process related and degradation impurities of acrivastine and validation of HPLC method.
Kumar A; Devineni SR; Dubey SK; Kumar P; Srivastava V; Ambulgekar G; Jain M; Gupta DK; Singh G; Kumar R; Hiriyanna SG; Kumar P
J Pharm Biomed Anal; 2017 Jan; 133():15-26. PubMed ID: 27969063
[TBL] [Abstract][Full Text] [Related]
10. Isolation, identification and characterization of potential impurities of anidulafungin.
Zhao L; Wang Q; Bie Y; Lu X
J Pharm Biomed Anal; 2017 Jul; 141():192-199. PubMed ID: 28448888
[TBL] [Abstract][Full Text] [Related]
11. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
12. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
[TBL] [Abstract][Full Text] [Related]
13. Structural Analysis and Quantitative Determination of Clevidipine Butyrate Impurities Using an Advanced RP-HPLC Method.
Zhou Y; Zhou F; Yan F; Yang F; Yao Y; Zou Q
J Chromatogr Sci; 2016 Mar; 54(3):353-60. PubMed ID: 26489435
[TBL] [Abstract][Full Text] [Related]
14. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity.
Siva Kumar R; Sravan Kumar KV; Kondareddy L; Yogeshwara KR; Manish G; Jeenet J; Nitesh K
J Chromatogr Sci; 2018 May; 56(5):383-395. PubMed ID: 29474520
[TBL] [Abstract][Full Text] [Related]
15. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
[TBL] [Abstract][Full Text] [Related]
16. Identification, synthesis and structural confirmation of process-related impurities in proparacaine hydrochloride.
Yang Z; Zhao J; Feng Y; Lei Y; Liu D; Qin F; Zheng J; Wang S
J Pharm Biomed Anal; 2020 Oct; 190():113497. PubMed ID: 32798917
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
18. Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process.
Cui D; Li Y; Lian M; Yang F; Meng Q
Analyst; 2011 Aug; 136(15):3149-56. PubMed ID: 21695344
[TBL] [Abstract][Full Text] [Related]
19. Stability-Indicating RP-HPLC Method for the Estimation of Process-Related Impurities and Degradation Products in Fesoterodine Fumarate by Using a Mass Spectrometric Compatible Mobile Phase.
Kumar N; Sangeetha D; Kalyanraman L
J Chromatogr Sci; 2021 Jan; 59(2):154-164. PubMed ID: 33190158
[TBL] [Abstract][Full Text] [Related]
20. Structural elucidation of the impurities in Enzalutamide bulk drug and the development, validation of corresponding HPLC method.
Ma X; Zhou W; Zou Q; Ouyang P
J Pharm Biomed Anal; 2016 Nov; 131():436-443. PubMed ID: 27664386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
